We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.175 | -4.12% | 4.075 | 4.00 | 4.15 | 4.25 | 4.075 | 4.25 | 1,068,871 | 11:57:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -11.90 | 26.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/10/2021 15:00 | This idiot or lying fraudster (or both) has just presided over the share price DROPPING BY TWO-THIRDS (offer to bid) in eight months, and dares to call others muppets. ;D and popcorn-time. Eight month report: EDEN-victims: About -64% ME (incl 2.7% reinvested divs): +19.1% ;D | neutralpov | |
15/10/2021 12:47 | AFN's charts only go back to 2011: | neutralpov | |
15/10/2021 12:45 | 123Trev 15 Oct '21 - 12:00 - 10780 > Did say this would be 2p some time back well on the way I see. Correct. This DB is infested by a few trolls like spadeychops (supersonico sold out and ran), halfwit PIs like weywey and nor-thick, and a paid bluey ramper barrelboi who works for the PR outfit and, as is the norm on DBs, multiple avatars/socks/IDs. The latter are in criminal breach of FSMA2000 etc., and, were it up to me, I'd despatch the latter group personally (and slowly.... know what I mean?). And then they're some intelligent honest posters, like yourself, erin, ravenna, me - truth-tellers about this disgusting scam. | neutralpov | |
15/10/2021 12:00 | Did say this would be 2p some time back well on the way I see. | 123trev | |
15/10/2021 11:58 | Your incompetence extends to your (pathetic attempts at a) troll. | neutralpov | |
15/10/2021 10:48 | All this to distract from the share price Down she goes!!!!!!!!!!!!!!!! (ROTFL) | neutralpov | |
15/10/2021 09:13 | spadeychops 15 Oct '21 - 08:23 - 10769 > Yawn… bored! ROFL! Sold up and ran, I see. Ungrateful cur, why didn't you thank us? | neutralpov | |
15/10/2021 08:58 | Continues to drop today. Just look at the trades... As the penny gradually drops with our thicker brethren, so does the share price | neutralpov | |
14/10/2021 22:46 | Is there really any difference in the WORDSOUP and CLAIMSTEW BS-Borscht from this mongrel dog of an AIM "share" between the blabbering from 2005, 2010, 2015 and now? Doesn't seem like there's much of a change to me. Some different names. But never any dosh. Phases to come: Dilution Extermination - 0p in the £. | neutralpov | |
14/10/2021 16:51 | Investing: Eden is very good at fine words, but less so at delivering sales. Perhaps to repeat myself, we have had 'significant' agreements in the past, none of which have generated sales. A few examples from Eden's annual reports and correspondence below. Is anyone surprised that markets no longer take Eden seriously. October 2004 Eden announced that heads of agreement have been agreed with Thallo Eco Products Corporation to distribute the nematode treatment product extensively in the US with minimum royalties of US$15m over 10 years. Outcome: No payments forthcoming. Eden announced that significant sales would deliver in 2005/06. Outcome: Turnover 2005 zero; 2006 102,559! Jan 2006 Eden announced that the first product to be marketed under the Redestos agreement will be Eden’s encapsulated fungicidal product for treating botrytis, with anticipated revenues starting in 2007. Outcome: no marketing, Eden mired in EU approval process and regulation. May 2006: personal letter: 'obtaining approval for use of 3AEY in this major market (USA) within two years maximum". Outcome: 2021 - still no US approval - unless I have missed something. May 2006: (same letter): ' We do expect the product to soon be available in most major wine growing regions. Outcome: 2021 - sales minimal. August 2007: 'concluded a major manufacturing and distribution agreement for Western Europe and the USA with Cheminova....this compliments the comapny's existing partnerships with Redestos SA in Greece and the Balkans, Zagro PTE in SE Asic and Xeda Intl in the post harvest sector. Cheminova is likely to start selling in Italy and Spain, then moving into France and Germany. Initial sales are likely to be small in 2008, with a full sales programme in 2009. Outome: non delivery. Sales still non-existent in 2012/2013 - £44k & £80k respectively. | erinvale1 | |
14/10/2021 16:50 | Investingisatrickyga > Annual Report 2020 From the Chairman's Statement > "We have been delighted ... We have high hopes" Their delight. Their high hopes. The idiot punters' dosh, though. ROTFL!! | neutralpov | |
14/10/2021 16:24 | spadeychops 14 Oct '21 - 12:59 - 10761 > I clearly do know more than you, as I know for FACT, <—— look the word up, investing[isatrickyg So stooopid and easy to trap. Thanks for admitting you are one and the same person or on the same ramping team. Any railway tracks near where you hang out? | neutralpov | |
14/10/2021 15:45 | Annual Report 2020 From the Chairman's Statement "We have been delighted to sign our first commercial agreement for seed treatment applications, which grants exclusive distribution rights of our proprietary product incorporating our Sustaine technology to Corteva Sciences, the fourth largest agricultural company in the world. We have high hopes for the commercial potential for this product area" "The recently announced agreement with Corteva is, of course, significant to Eden" "Eden is well positioned to capitalise on this trend (Growing food to feed larger populations more sustainably) as its products and technologies align closely with global demand for plastic-free and sustainable crops" | investingisatrickygame |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions